z-logo
open-access-imgOpen Access
Neuroprotection in Perimenopause New Insights for Hormone Therapy
Publication year - 2020
Publication title -
journal of clinical review and case reports
Language(s) - English
Resource type - Journals
ISSN - 2573-9565
DOI - 10.33140/jcrc.05.04.03
Subject(s) - neuroprotection , menopause , brain aging , window of opportunity , neuroscience , dementia , dopamine , medicine , estrogen , endocrine system , psychology , hormone therapy , hormone , endocrinology , cognition , disease , real time computing , computer science , cancer , breast cancer
Endocrine and Neural Senescence overlap by intertwined complexfeedback loops. The variable levels of estradiol, progesterone,DHEA(S), and neurotransmitters -GABA, serotonin, dopamineand glutamate dependent on sexual steroids make women’s brainto suffer from the menarche to menopause, perimenopause beinga “critical period”, “a neurological transition state” offering to thescientific and medical communities a “window of opportunity” todelay the onset of brain aging, The modern medical communitiesare moving from focusing on the treatment of already identifieddementia to develop strategies for accurate depiction of predementiaconditions/risk factors for brain aging, for prevention and slowinga demented status to progress from early stages of endocrine agingprocess [1].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom